Last reviewed · How we verify

NCT06133855

Impact of Electromagnetic Field Therapy on Pain and Function in Patients With Mechanical Back Pain

Completed NA Last updated 5 March 2024
What this trial tests

NA trial testing Pulsed electromagnetic field in Mechanical Low Back Pain in 30 participants. Completed in 29 February 2024.

Timeline
1 December 2023
Primary endpoint
29 February 2024
29 February 2024

Quick facts

Lead sponsorCairo University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment30
Start date1 December 2023
Primary completion29 February 2024
Estimated completion29 February 2024
Sites1 location across Saudi Arabia

Drugs / interventions tested

Conditions studied

Sponsor

Cairo University

Who can join

Adults 20 to 40, any sex, with Mechanical Low Back Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to investigate the impact of electromagnetic field therapy on pain severity and functional disability in mechanical back pain patients suffering from myofascial trigger points.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Effectiveness of Electromagnetic Field Therapy in Mechanical Low Back Pain: A Randomized Controlled Trial.
    Koura GMR, Elshiwi AMF, Alshahrani MS, Elimy DA, et al · · 2025 · cited 2× · PMID 40078750 · DOI 10.2147/jpr.s500698

Verify or expand the search:

Other trials of Pulsed electromagnetic field

Trials testing the same drug.

Other recruiting trials for Mechanical Low Back Pain

Currently open trials in the same condition.

Other Cairo University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06133855.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing